Medication info

Lafutah Tablet 10 mg (Lafutidine)

Prescription medicationTabletExpired
Ingredient · strength
Lafutidine›10mg / 1 tablet
Manufacturer / importer
Aprogen Biologics Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 202002083 · Approved 2020.03.25

This product's status changed to Expired on 2025.03.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastrointestinal disorders (ulcers, gastritis, reflux esophagitis, etc.), use in combination for eradication therapy, and pre-anesthetic medication
Who uses it
Adults
Adult dosage
1. Short-term treatment of gastric ulcers: The usual dose is lafutidine 10mg per dose orally twice daily, in the morning and at bedtime. Clinical trials of up to 8 weeks showed healing in most patients within 8 weeks; however, the healing period may occasionally vary from patient to patient. 2. Short-term treatment of duodenal ulcers: The usual dose is lafutidine 10mg per dose orally twice daily, in the morning and at bedtime. Clinical trials of up to 6 weeks showed healing in most patients within 6 weeks; however, the healing period may occasionally vary from patient to patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is lafutidine 10mg orally once daily at bedtime. Clinical trials of up to 2 weeks showed healing in most patients within 2 weeks; however, the healing period may occasionally vary from patient to patient. 4. Concomitant antibiotic therapy in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia: The usual dose is lafutidine 10mg per dose orally twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer lafutidine 10mg per dose orally twice daily.

Ingredients

Manufacturer
Aprogen Biologics Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (ulcers, gastritis, reflux esophagitis, etc.), use in combination for eradication therapy, and pre-anesthetic medication

  • Gastric ulcer
  • duodenal ulcer
  • gastric mucosal lesions from acute gastritis
  • chronic gastritis
  • peptic ulcer
  • gastroesophageal reflux disease
View approved original text

This medication is used for the treatment of gastric ulcers and duodenal ulcers. It also helps improve mucosal damage caused by acute and chronic gastritis and is administered in combination with antibiotics for patients with peptic ulcers caused by Helicobacter pylori infection. It is effective in reducing gastric acidity when given before anesthesia and is also effective for treating gastroesophageal reflux disease. Overall, it is used to relieve symptoms of various gastrointestinal disorders and assist in recovery.

Dosage and Administration

Adult dosage

1. Short-term treatment of gastric ulcers: The usual dose is lafutidine 10mg per dose orally twice daily, in the morning and at bedtime. Clinical trials of up to 8 weeks showed healing in most patients within 8 weeks; however, the healing period may occasionally vary from patient to patient. 2. Short-term treatment of duodenal ulcers: The usual dose is lafutidine 10mg per dose orally twice daily, in the morning and at bedtime. Clinical trials of up to 6 weeks showed healing in most patients within 6 weeks; however, the healing period may occasionally vary from patient to patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is lafutidine 10mg orally once daily at bedtime. Clinical trials of up to 2 weeks showed healing in most patients within 2 weeks; however, the healing period may occasionally vary from patient to patient. 4. Concomitant antibiotic therapy in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 or 14 days. 5. Premedication for anesthesia: The usual dose is lafutidine 10mg per dose orally twice (at bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer lafutidine 10mg per dose orally twice daily.

Precautions

This medication should not be used in patients with an allergy to any component of this medication. Since this medication contains lactose, patients with genetic diseases that do not allow for lactose digestion should avoid taking it. Patients with a history of drug allergy symptoms should use this medication with caution. Patients with poor liver function or kidney problems, as well as those undergoing dialysis, should exercise caution when using this medication. Elderly individuals may have decreased physical function and should take this medication carefully, adjusting doses and intervals. During the administration of this medication, allergic reactions or shock symptoms may occur; if symptoms such as facial pallor, decreased blood pressure, or difficulty breathing appear, discontinue use immediately and seek medical assistance. Liver dysfunction or symptoms of jaundice may occur, so regular liver function tests are recommended, and if abnormalities are found, discontinue use of the medication. There may be side effects resulting in a decrease in blood cell count, so if symptoms such as pharyngitis, general malaise, or fever arise, consult a healthcare professional immediately. In addition, rare but serious side effects such as skin rashes, seizures, and cardiac rhythm abnormalities have been reported, so inform your healthcare provider immediately if any unusual symptoms occur. Various mild side effects such as abdominal pain, diarrhea, constipation, headache, and fatigue may occur; inform your healthcare provider if symptoms persist or worsen. If gastric cancer or malignant tumors are suspected, this medication may mask symptoms, so testing must be carried out to confirm malignancy. Pregnant or breastfeeding women should take this medication only if absolutely necessary, and particularly breastfeeding women are advised to avoid it as it may be secreted in breast milk. Safety in children has not been thoroughly established, so it is advisable not to use it in pediatric patients. This medication should be stored out of reach of children, kept in its original container, and transferring to another container should be avoided. There is no carcinogenic risk associated with long-term use of this medication, but some endocrine cell changes were observed in animals at high doses. Consult with a healthcare professional adequately before and after use to ensure safe use tailored to individual health conditions.

Side effects

  • Shock
  • anaphylaxis symptoms
  • facial pallor
  • hypotension
  • generalized rash
  • dyspnea
  • hepatic impairment
  • jaundice
  • agranulocytosis
  • pharyngitis
Show 79 more
  • generalized malaise
  • fever
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • seizures
  • interstitial nephritis
  • Stevens-Johnson syndrome
  • Lyell's syndrome
  • rhabdomyolysis
  • atrioventricular block
  • impaired contraction
  • constipation
  • diarrhea
  • hard stool
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • headache
  • insomnia
  • drowsiness
  • reversible confusional state
  • hallucinations
  • altered consciousness
  • dizziness
  • chills
  • flushing
  • leukocytosis
  • eosinophilia
  • leukopenia
  • erythrocytopenia
  • decrease in hematocrit
  • increase in ALT
  • increase in AST
  • increase in Al-P
  • increase in γ-GTP
  • increase in T-Bil
  • increase in LDH
  • increase in TTT
  • abnormal urinary protein
  • increase in BUN
  • increase in serum uric acid
  • increase in Cl
  • delayed renal function
  • increase in Na
  • decrease in K
  • gynecomastia
  • edema
  • malaise
  • glossitis
  • headache
  • urticaria
  • skin rash
  • abdominal pain
  • dyspepsia
  • enteritis
  • gastric ulcer
  • erosive gastritis
  • duodenitis
  • bloating
  • nasopharyngitis
  • upper respiratory infection
  • bronchopneumonia
  • tinea
  • cough
  • oropharyngeal pain
  • oropharyngeal discomfort
  • wet cough
  • fatigue
  • chest pain
  • limb pain
  • arthralgia
  • neck pain
  • pruritus
  • acne
  • contusion
  • insomnia
  • non-alcoholic fatty liver disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.